✨
AI Summary
- Dr. Matthew Johnson explores clinical trials on psilocybin, MDMA, ayahuasca, DMT, and LSD for treating depression, addiction, trauma, eating disorders, and ADHD
- Johnson describes optimal conditions for psychedelic experiments in labs, including setup procedures and variables that influence clinical outcomes
- Episode addresses misconceptions, potential hazards, flashbacks, at-risk populations, and the evolving legal and pharmaceutical landscape for psychedelic medicine
Guests on This Episode
MJ
Matthew Johnson
2 podcast appearances